Numerous studies have investigated the significance of HER2 amplification and overexpression across different cancer types, from lung cancer to rare cases such as Paget’s disease of the skin, as well as the mechanisms of action and resistance to HER2-targeted drugs like trastuzumab [44,45]. Here, ERBB2 is linked to lung carcinoma.